Biodistribution of p-boronophenylalanine in patients with glioblastoma multiforme for use in boron neutron capture therapy

Neurosurgery

Volumn 42, Issue 3, 1998, Pages 463-469

  Elowitz, Eric H ^a,b   Bergland, Richard M ^a   Coderre, Jeffrey A ^b   Joel, Darrel D ^c   Chadha, Manjeet ^d   Chanana, Arjun D ^a  

^a Department of Neurosurgery ^*  (United States)

^b BETH ISRAEL MEDICAL CENTER   (United States)

^c Medical Department   (United States)

^d BROOKHAVEN NATIONAL LABORATORY   (United States)

Author keywords

Boron neutron capture therapy; Boronophenylalanine; Glioblastoma multiforme

Indexed keywords

4 BORONOPHENYLALANINE B 10;

ARTICLE; BRAIN SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; CRANIOTOMY; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG TISSUE LEVEL; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEUTRON CAPTURE THERAPY; PRIORITY JOURNAL;

BORON COMPOUNDS; BRAIN; BRAIN NEOPLASMS; CRANIOTOMY; GLIOBLASTOMA; HUMANS; INJECTIONS, INTRAVENOUS; NEUTRON CAPTURE THERAPY; OSMOLAR CONCENTRATION; PHENYLALANINE; RADIATION-SENSITIZING AGENTS; SCALP; TISSUE DISTRIBUTION;

EID: 0031931969     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-199803000-00004     Document Type: Article

References (22)

1. Bergland R, Elowitz E, Coderre J, Joel D, Chadha M: A phase-1 trial of intravenous boronophenylalanine-fructose complex in patients with glioblastoma multiforme, in Mishima Y (ed): Cancer Neutron Capture Therapy. New York, Plenum Press, 1996, pp 739-745.
2. Coderre JA: A phase 1 biodistribution study of p-boronophenylalanine, in Moss R, Gabel D (ed): Boron Neutron Capture Therapy: Towards Clinical Trials of Glioma with BNCT. New York, Plenum Press, 1992, pp 111-121.
3. Coderre JA, Button TM, Micca PL, Fisher C, Nawrocky MM, Liu HB: Neutron capture therapy of the 9L gliosarcoma using the p-boronophenylalanine-fructose complex. Int J Radial Oncol Biol Phys 30:643-652, 1994.
4. Coderre JA, Elowitz EH, Chadha M, Bergland R, Capala J, Joel D, Liu HB, Slatkin DN, Chanana AD: Boron neutron capture therapy for glioblastoma multiforme using p-boronophenylalanine and epithermal neutrons: Trial design and early clinical results. J Neurooncol 33:141-152, 1997.
5. Coderre JA, Glass JD, Fairchild RG, Micca PL, Fand I, Joel DD: Selective delivery of boron by the melanin precursor analogue p-boronophenylalanine to tumors other than melanoma. Cancer Res 50:138-141, 1990.
6. Coderre JA, Joel DD, Micca PL, Nawrocky MM, Slatkin DN: Control of intracerebral gliosarcoma in rats by boron neutron capture therapy with p-boronophenylalanine. Radiât Res 129: 290-296,1992.
7. Coderre JA, Makar MS, Micca PL, Nawrocky MM, Liu HB, Joel DD, Slatkin DN, Amols HI: Derivations of relative biological effectiveness for the high-LET radiations produced during boron neutron capture irradiations of the 9L rat gliosarcoma in vitro and in vivo. Int J Radiat Oncol Biol Phys 27:1121-1129, 1993.
8. 7Li reaction. Med Phys 13:50-56, 1986.
9. Farr LE, Sweet WE, Robertson JS, Foster CG, Locksley HB, Suntherland DL, Mendelsohn ML, Stickly EE: Neutron capture therapy with boron in the treatment of glioblastoma multiforme. AJR Am J Roentgenol 71:279-291,1954.
10. Fukuda H, Hiratsuka J, Honda C, Kobayashi T, Yoshino K, Karashima H, Takahashi J, Abe Y, Kanda K, Ichihashi M, Mishima Y: Boron neutron capture therapy of malignant melanoma using 10B-paraboronophenylalanine with special reference to evaluation of radiation dose and damage to the normal skin. Radiat Res 138:435-442,1994.
11. Gavin PR, Kraft SL, Huiskamp R, Coderre JA: A review: CNS effects and normal tissue tolerance in dogs. J Neurooncol 33:71-80,1997.
12. Hatanaka H, Nakagawa Y: Clinical results of long-surviving brain tumor patients who underwent boron neutron capture therapy. Int J Radial Oncol Biol Phys 28:1061-1066, 1994.
13. Joel DD, Coderre JA, Nawrocky MM, Slatkin DN, Chanana AD: Biodistribution of p-boronophenylalanine: Uptake into glioblastoma multiforme correlates with tumor cellularity. Presented at the Seventh International Symposium on Neutron Capture Therapy for Cancer, Zurich, Switzerland, September 4-7, 1996.
14. Kabalka GW, Hubner KF, Smith GT, Reid WS, Longford CPD, Roberts TG, Reddy NK, Srivastava R, Narayana C, Buonocore E: Synthesis and preliminary evaluation of boronated agents labeled with positron emitting isotopes for use in boron neutron capture therapy treatment planning. Presented at the Seventh International Symposium on Neutron Capture Therapy for Cancer, Zurich, Switzerland, September 4-7, 1996.
15. Mallesch JL, Moore DE, Allen BJ, McCarthy VVH, Jones R, Sterling WA: The pharmacokinetics of p-boronophenylalanine-fructose in human patients with glioma and metastatic melanoma. Int J Radial Oncol Biol Phys 28:1183-1188, 1994.
16. 10B compound. Lancet 2:388-389, 1989.
17. Mishima Y, Ichihashi M, Honda C, Shiono M, Nakagawa T, Obara H, Shirakawa J, Hiratsuka J, Kanda K, Kobayashi T, Nozaki T, Aigawa O, Sato T, Karashima H, Yoshino K, Fukuda H: Advances in the control of cutaneous primary and metastatic melanoma by thermal neutron capture therapy, in Allen B, Moore D, Harrington B (eds): Progress in Neutron Capture Therapy for Cancer. New York, Plenum Press, 1992, pp 577-583.
18. Mori Y, Suzuki A, Yoshino K, Kanihana H: Complex formation of p-boronophenylalanine with some monosaccharides. Pigment Cell Res 2:273-277,1989.
19. Morris GM, Coderre JA, Hopewell JVV, Micca PL, Nawrocky MM, Liu HB, Bywaters A: Response of the central nervous system to boron neutron capture irradiation: Evaluation using rat spinal cord model. Radiother Oncol 32:249-255, 1994.
20. Slatkin DN: A history of boron neutron capture therapy of brain tumors. Brain 114:1609-1629,1991.
21. Smith DR, Chandra S, Coderre JA, Morrison GH: Ion microscopy imaging of 10B from p-boronophenylalanine in a brain tumor model for boron neutron capture therapy. Cancer Res 56:4302-4306,1996.
22. Yoshino K, Suzuki A, Mori Y, Kanihana H, Honda C, Mishima Y, Kobayashi T, Kanda K: Improvement of solubility of p-boronophenylalanine by complex formation with monosaccharides. Strahlenther Onkol 165:127-129, 1989.